Literature DB >> 15302905

Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.

Ulrike Leiter1, Petra G Buettner, Thomas K Eigentler, Claus Garbe.   

Abstract

PURPOSE: The increasing number of thin cutaneous melanomas (CM) with tumor thickness up to 1 mm demands a detailed analysis of prognostic factors for the classification and grading of these tumors. The aim of the present study was to identify prognostic factors in thin CM. PATIENTS AND METHODS: A series of 12,728 patients with thin incident primary invasive CM and follow-up data recorded between 1976 and 2000 by the German-based Central Malignant Melanoma Registry was analyzed using the multivariate Cox proportional hazard model to evaluate prognostic factors, and classification and regression trees analysis (CART) to define prognostic groups.
RESULTS: Multivariate analysis found tumor thickness, sex, age, body site, and histopathologic subtype to be significant prognostic factors of thin CM. Ulceration and regression did not affect prognosis significantly. Prognostic classification based on the results of CART analysis resulted in three groups defined by tumor thickness, age, and sex. Ten-year survival rates of these groups varied between 91.8% and 98.1%, with improved classification as compared with subgroups by tumor thickness alone.
CONCLUSION: Classification by tumor thickness identified prognostic subgroups with highest significance in thin CM, and the classification was improved by the introduction of age and sex. However, neither ulceration nor the level of invasion included in the new American Joint Committee on Cancer TNM system classification, revealed statistical significance as prognostic factors in thin CM.

Entities:  

Mesh:

Year:  2004        PMID: 15302905     DOI: 10.1200/JCO.2004.03.074

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  14 in total

Review 1.  A review of sentinel lymph node biopsy for thin melanoma.

Authors:  K M Joyce; N M McInerney; C W Joyce; D M Jones; A J Hussey; P Donnellan; M J Kerin; J L Kelly; P J Regan
Journal:  Ir J Med Sci       Date:  2014-11-01       Impact factor: 1.568

2.  Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.

Authors:  Phyllis A Gimotty; Ronald Shore; Nancy L Lozon; Jeanne Whitlock; Sidan He; Fawn D Vigneau; Lois Dickie; David E Elder; Xiaowei Xu; Ann G Schwartz; DuPont Guerry
Journal:  J Invest Dermatol       Date:  2016-06-25       Impact factor: 8.551

3.  Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.

Authors:  Naoki Hiramatsu; Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Fuminaka Sugauchi; Akihiro Tamori; Sei Kakinnuma; Kentaro Matsuura; Namiki Izumi
Journal:  J Gastroenterol       Date:  2011-06-17       Impact factor: 7.527

Review 4.  Follow-up in patients with low-risk cutaneous melanoma: is it worth it?

Authors:  Ulrike Leiter; Thomas Eigentler; Claus Garbe
Journal:  Melanoma Manag       Date:  2014-12-04

5.  Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation.

Authors:  Tomohiro Tanaka; Michael D Voigt
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-23       Impact factor: 4.553

6.  Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

Authors:  Richard L White; Gregory D Ayers; Virginia H Stell; Shouluan Ding; Jeffrey E Gershenwald; Jonathan C Salo; Barbara A Pockaj; Richard Essner; Mark Faries; Kim James Charney; Eli Avisar; Axel Hauschild; Friederike Egberts; Bruce J Averbook; Carlos A Garberoglio; John T Vetto; Merrick I Ross; David Chu; Vijay Trisal; Harald Hoekstra; Eric Whitman; Harold J Wanebo; Daniel Debonis; Michael Vezeridis; Aaron Chevinsky; Mohammed Kashani-Sabet; Yu Shyr; Lynne Berry; Zhiguo Zhao; Seng-Jaw Soong; Stanley P L Leong
Journal:  Ann Surg Oncol       Date:  2011-06-07       Impact factor: 5.344

7.  WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma.

Authors:  Santiago Saavedra-Alonso; Pablo Zapata-Benavides; Ana Karina Chavez-Escamilla; Edgar Manilla-Muñoz; Diana Elisa Zamora-Avila; Moisés Armides Franco-Molina; Cristina Rodriguez-Padilla
Journal:  Exp Ther Med       Date:  2016-10-27       Impact factor: 2.447

8.  Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.

Authors:  Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Hiroshi Yatsuhashi; Namiki Izumi
Journal:  J Gastroenterol       Date:  2010-09-10       Impact factor: 7.527

9.  Sentinel node metastasectomy in thin <or=1-mm melanoma.

Authors:  Ilkka Koskivuo; Erkki Suominen; Juha Niinikoski; Lauri Talve
Journal:  Langenbecks Arch Surg       Date:  2005-07-29       Impact factor: 3.445

10.  A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection.

Authors:  Kazuhiro Saso; Norikatsu Myoshi; Shiki Fujino; Yuya Takenaka; Yusuke Takahashi; Junichi Nishimura; Masayoshi Yasui; Masayuki Ohue; Masayoshi Tokuoka; Yoshito Ide; Hidekazu Takahashi; Naotsugu Haraguchi; Taishi Hata; Chu Matsuda; Tsunekazu Mizushima; Yuichiro Doki; Masaki Mori
Journal:  Mol Clin Oncol       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.